This edition of our biweekly newsletter for directors and investors includes articles on CalPERS claiming success in the 2016 proxy season, FASB asking for comments on its conceptual framework and topics for its future agenda, and more.
Boards can help companies prepare by asking management the right questions.
This edition of our biweekly newsletter for directors and investors includes articles on the CII suggesting changes to the PCAOB’s auditor’s reporting model reproposal, CalSTRS updating its Corporate Governance Principles, and more.
Do pharmaceutical and life sciences company directors have the right skills and expertise for the New Health Economy?
This edition of our biweekly newsletter for directors and investors includes articles on the SEC seeking to simplify disclosure requirements, SASB releasing guidance to enhance investor engagement on sustainability issues, and more.
In this recorded webcast we discuss prominent investors' views on companies’ and boards’ engagement efforts, proxy access, and more.
Increasingly, boards are reaching out to shareholders about executive compensation. We explore why shareholder engagement is important, and how boards can do it best.
No company is safe from hedge fund activism. Activists have massive assets under management, and they target companies of all sizes, in all industries. What can you do to get ahead of an activist situation?
This edition of our biweekly newsletter for directors and investors includes articles on the potential impact the British exit from EU vote could have on US companies, the PCAOB’s guidance for the new audit partner form, and more.
The use of non-GAAP financial measures is surging, and the SEC is noticing.